Article
Comprehensive mutation screening in a cystic fibrosis center.
Pediatrics - 1 Feb 2001
Wine J J, Kuo E, Hurlock G, Moss R B
Abstract excerpt
OBJECTIVES AND BACKGROUND: The identities of a cystic fibrosis (CF) patient's CFTR mutations can influence therapeutic strategies, but because >800 CFTR mutations exist, cost-effective, comprehensive screening requires a multistage approach. Single-strand conformation polymorphism and heteroduplex analysis (SSCP/HA) can be an important part of mutation detection, but must be calibrated within each laboratory. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
